SOLV logo

SOLVSolventum Corp

$79.22
$1.72
(2.13%)
Today
Closed $79.22
$0.8914
(1.13%)
After Hours
Updated: 07:40 PM EDT
EarningsAug 6
Mkt Cap$14.02B
Vol1.45M
News
all
press releases
Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Zacks
News Placeholder
More News
News Placeholder
Solventum Trends for 2026: AI Coding, Tariffs, and Margins
SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.
Zacks
News Placeholder
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Solventum to Participate in the 2026 Jefferies Healthcare Conference
Solventum to Participate in the 2026 Jefferies Healthcare Conference Solventum to Participate in the 2026 Jefferies Healthcare Conference PR Newswire EAGAN, Minn., May 27, 2026 EAGAN, Minn., May 27, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a...
PR Newswire
News Placeholder
SOLV or HQY: Which Is the Better Value Stock Right Now?
SOLV vs. HQY: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Zacks
News Placeholder
Solventum to Participate in the 2026 BofA Securities Health Care Conference
Solventum to Participate in the 2026 BofA Securities Health Care Conference Solventum to Participate in the 2026 BofA Securities Health Care Conference PR Newswire ST. PAUL, Minn., May 7, 2026 ST...
PR Newswire
News Placeholder
Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Zacks
News Placeholder
Solventum (NYSE:SOLV) Price Target Cut to $70.00 by Analysts at Wells Fargo & Company
Wells Fargo & Company cut their price objective on Solventum from $83.00 to $70.00 and set an "equal weight" rating for the company in a research report on Wednesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.